about
Novel derivatives of polymyxinsNovel formulations for antimicrobial peptidesDermatophytic defensin with antiinfective potentialEvaluation of multidrug efflux pump inhibitors by a new method using microfluidic channelsA unified conformational selection and induced fit approach to protein-peptide dockingVirtual Screening of Peptide and Peptidomimetic Fragments Targeted to Inhibit Bacterial Dithiol Oxidase DsbAAntimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniaeEfficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected WoundSimulating the mechanism of antimicrobial lipopeptides with all-atom molecular dynamics.Mapping residue-specific contacts of polymyxin B with lipopolysaccharide by saturation transfer difference NMR: insights into outer-membrane disruption and endotoxin neutralization.Comparative efficacy analysis of anti-microbial peptides, LL-37 and indolicidin upon conjugation with CNT, in human monocytesAn FPGA implementation to detect selective cationic antibacterial peptides.A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membraneAxinellamines as broad-spectrum antibacterial agents: scalable synthesis and biology.Designing of peptides with desired half-life in intestine-like environment.Immune activation efficacy of indolicidin is enhanced upon conjugation with carbon nanotubes and gold nanoparticlesA microfluidic device for simple and rapid evaluation of multidrug efflux pump inhibitorsEfficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models.Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens.ATP synthase: a molecular therapeutic drug target for antimicrobial and antitumor peptidesHydrophilic/hydrophobic characters of antimicrobial peptides derived from animals and their effects on multidrug resistant clinical isolates.Determination of comparative minimum inhibitory concentration (MIC) of bacteriocins produced by enterococci for selected isolates of multi-antibiotic resistant Enterococcus spp.Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development.LPS inmobilization on porous and non-porous supports as an approach for the isolation of anti-LPS host-defense peptides.A broad-spectrum bactericidal lipopeptide with anti-biofilm properties.Probing the "charge cluster mechanism" in amphipathic helical cationic antimicrobial peptides.Thermodynamics of RTA3 peptide binding to membranes and consequences for antimicrobial activity.Mechanisms mediating bactericidal properties and conditions that enhance the potency of a broad-spectrum oligo-acyl-lysyl.Novel peptide inhibiting both TEM-1 β-lactamase and penicillin-binding proteins.Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo.Synthesis of a polymyxin derivative for photolabeling studies in the gram-negative bacterium Escherichia coli.Novel Peptides from Skins of Amphibians Showed Broad-Spectrum Antimicrobial Activities.Venom peptides cathelicidin and lycotoxin cause strong inhibition of Escherichia coli ATP synthase.LAB Bacteriocins Controlling the Food Isolated (Drug-Resistant) Staphylococci.Host Defence against Bacterial Biofilms: “Mission Impossible”?Control of Propionibacterium acnes by natural antimicrobial substances: Role of the bacteriocin AS-48 and lysozyme
P2860
Q26824934-80B39845-9D42-454D-AC7C-3D04E0D69E58Q26991771-5633EB75-23DB-4626-85DB-68A1427CC4B2Q27679095-658D191D-7184-4E80-9791-8A29874302FAQ28477724-85A95054-3F11-4D2C-B399-086D739BBE16Q28487957-151BBA05-99B9-4D7E-9F88-CF749C97869BQ28546904-83B04192-D90C-47C6-AE2E-C6CD8DDD21A1Q28547917-A9A9394E-C225-4A9A-B086-952B99F43FCAQ28552608-87DCC7BD-8C26-4CFA-A717-E38303E4A1FEQ33647074-81EC98D2-FD27-4073-AA6A-846139389282Q33648928-FC6A261E-5C3D-47DA-B2EC-2F352F5CD7A2Q33792343-8BAB3E77-5A27-4389-8D91-5AB036B3435CQ33954861-F3F83ED6-7F81-4018-B20D-3D62745127C8Q34045186-1C266270-0F67-4568-9256-84473B397931Q34489878-5F0FBC7C-6E6B-4AFE-B82C-87B89B3B265FQ35228840-CC4090C2-BA7C-4DF5-9A86-1DCD749C9C2CQ35433503-87DC3238-0B6C-4ABC-9C39-AE9EABDC4330Q35743161-C09B70FE-E5BE-4AA4-9561-1F62BC42FBE0Q36018591-DA954263-F130-4CD2-BB93-9925A10A107FQ36505406-F0F61879-2A9D-450E-91F4-F014AA62BC73Q36525469-7D9B1313-5DF9-4781-95B2-7155C45F1003Q36912403-AAF46D18-A18F-4C8E-996F-BE5788746F91Q37354728-BB75983D-5E1E-413A-881A-B4CEB28A05E8Q37894693-5BA5C3D0-6B0E-437B-9C01-A87E83A3C496Q38177267-7448A82B-69DB-4CC8-A68D-EA79F2B15779Q40205283-EDA6A2CA-8E81-415C-8709-EE95055067C4Q40490579-75EC6D1D-E055-449A-92B5-C3A400C50149Q40791392-D72BB77F-FFBA-43C2-A910-15317A3DEFB8Q42041041-43C79AFA-90AF-419A-A3E8-754B9D507B70Q42838785-418CEBE5-A5D6-4145-BF5E-8B7C2F81721EQ47723258-6220BDCF-DAB3-498A-852B-8B5E429A8AB1Q52657040-4129F0C1-01EC-4C20-BF3D-3FDD41607F80Q53316925-2363585A-B23D-4638-B9BE-E4E1AC5EE630Q54249955-41284B20-00F2-4F8F-872E-6C5AB838DCC8Q55359747-D5297464-0AE7-4A68-9C73-6720AEEE8B6EQ58692848-DCB84F01-6062-42EC-B9F7-84CB5AD294FAQ58799513-016C388A-5E0B-449C-A964-47D00495EDA4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New approaches in peptide antibiotics.
@en
New approaches in peptide antibiotics.
@nl
type
label
New approaches in peptide antibiotics.
@en
New approaches in peptide antibiotics.
@nl
prefLabel
New approaches in peptide antibiotics.
@en
New approaches in peptide antibiotics.
@nl
P1476
New approaches in peptide antibiotics.
@en
P2093
Martti Vaara
P304
P356
10.1016/J.COPH.2009.08.002
P577
2009-09-06T00:00:00Z